PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsFertility regulator has amassed a £3.4m cash surplus

BioNews

Fertility regulator has amassed a £3.4m cash surplus

Published 20 February 2012 posted in News and appears in BioNews 645

Author

Vicki Kay

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.

The UK's fertility watchdog, the Human Fertilisation and Embryology Authority (HFEA), has amassed cash reserves of around £3.4 million from charges to the clinics it licenses, prompting calls for the money to be given back to those seeking IVF treatment....

The UK's fertility watchdog, the Human Fertilisation and Embryology Authority (HFEA), has amassed cash reserves of around £3.4 million from charges to the clinics it licenses, prompting calls for the money to be given back to those seeking IVF treatment.

The HFEA charges a £75 fee for every IVF cycle undertaken at one of its licensed clinics. For those receiving NHS treatment, the fee is paid for by the clinic, however some private clinics pass the charge onto their patients.

The full cost of an IVF cycle is between £4,000 and £8,000, according to estimates published by the HFEA. Some NHS clinics are denying patients the full three cycles recommended by National Institute for Health and Clinical Excellence (NICE) - or in some cases refusing treatment completely - as they say they cannot meet the cost.

'This comes at a time when NHS funding for infertility treatment such as IVF has been cut in many parts of the country', said Dr Allan Pacey, chairman of the British Fertility Society. 'The £3.4 million is a significant sum of money and by a conservative estimate would fund over 850 cycles of IVF treatment'.

The cash surplus - reported in the Health Service Journal - is equivalent to more than half of the HFEA's annual £6.2 million budget, which is funded partly by the Department of Health and partly by fees raised by the clinics it licenses. The HFEA cut the fee by 28 percent in October last year to prevent the surplus growing further, but many believe this isn't enough and that the money should be used to help patients.

'It would appear that the surplus has accumulated at least in part due to many patients who have been unable to access NHS treatment and been forced into the private sector', said Ms Clare Lewis-Jones of the charity Infertility Network UK. 'We strongly believe that the funds built up by the HFEA should be reinvested back into the area which they regulate and that infertility patients should in some way benefit from this excess'.

A spokesperson for the HFEA said that it had agreed with the Department of Health not to return the money to the clinics due to the 'complex principles and practicalities that would entail'. It said it had come up with a plan to spend the surplus 'wisely', but that this had been rejected by the Department of Health.

Ms Lewis-Jones responded: 'We would be interested to know what the HFEA had proposed in their plan to spend the surplus and why it was rejected by the Government'.

Related Articles

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
12 February 2021 • 2 minutes read

Concerns over 'no baby, no fee' programmes

by Bethany Muller

Campaigners have requested increased oversight over 'no baby, no fee' funding programmes offered by IVF clinics...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
13 March 2013 • 2 minutes read

Government launches consultation on future of UK human fertilisation and tissue regulators

by Ayesha Ahmad

The UK Government has launched a consultation on the future of the Human Fertilisation and Embryology Authority (HFEA) and Human Tissue Authority (HTA) amid proposals to transfer the regulators' functions elsewhere....

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
28 February 2013 • 1 minute read

Private equity firm invests in successful London IVF clinic

by Ruth Retassie

A London-based IVF clinic has received an investment from a private equity firm to open more fertility clinics in the UK and abroad....

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
13 February 2013 • 1 minute read

Smokers and obese people denied IVF by some NHS trusts

by Dr Rosie Morley

Nine NHS primary care trusts (PCTs) have introduced restrictions to IVF treatment for patients who smoke or are overweight...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
31 January 2013 • 3 minutes read

£3.4 million is a heck of a lot of money!

by Clare Lewis-Jones MBE

I was shocked when I heard the news that the Human Fertilisation and Embryology Authority (HFEA) has built up the princely sum of approximately £3.4 million in its bank account. The HFEA explains that this surplus has arisen over recent years due to prudent budgeting...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
30 January 2013 • 2 minutes read

Cut IVF multiple births to 10 percent, says HFEA

by Nishat Hyder

The rate of multiple births resulting from IVF treatment is to be no more than ten percent, announced the Human Fertility and Embryology Authority (HFEA), in the final stage of its policy to reduce IVF multiple birth rates in the UK....

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
28 January 2013 • 2 minutes read

£5.8m boost for mitochondrial disease research

by Dr Maria Botcharova

An experimental genetic technique to prevent serious diseases from passing between mother and child is to receive £5.8 million funding. The Wellcome Trust is contributing £4.4 million to the new Centre for Mitochondrial Research at Newcastle University...

PET BioNews
News
23 January 2013 • 2 minutes read

New law empowers UK Government to transfer HFEA's functions

by Sandy Starr

The Public Bodies Bill - which empowers the UK Government to transfer the functions of the Human Fertilisation and Embryology Authority (HFEA), the country's regulator of fertility treatment and embryo research - has received Royal Assent and has become the Public Bodies Act. This Act represents the realisation in statute of the Coalition Government's longstanding plans for a 'bonfire of the quangos'...

Image by Alan Handyside via the Wellcome Collection. Depicts equipment used for embryo biopsy.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts equipment used for embryo biopsy.
News
23 January 2013 • 1 minute read

Overstretched regulator to police IVF clinics

by Oliver Timmis

The Care Quality Commission (CQC) will take over policing of IVF clinics, despite worries it cannot cope with the additional workload...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
16 January 2012 • 3 minutes read

Crystal ball gazing: fertility treatment in 2012

by Professor Allan Pacey

Crystal ball gazing has never been my strong suit but I found myself rising to the challenge now that I have taken over the mantle of Chairman of the British Fertility Society. What is clear is that 2012 should turn out to be an interesting year...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Heart attack scars healed in stem cell safety trial

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

15 August 2022 • 2 minutes read

Call to end ban on HIV-positive partner gamete 'donation'

15 August 2022 • 2 minutes read

Melanoma invades new tissues using nerve cell gene

15 August 2022 • 2 minutes read

Exceeding alcohol limits could damage DNA and accelerate ageing

15 August 2022 • 2 minutes read

Blood cell gene mutations affect mitochondria, increasing cardiovascular disease risk

15 August 2022 • 2 minutes read

Jumping gene helps immune system fight viruses

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856